New ways in the fight against malignant brain tumors: Glioblastom research

Am 20. Dezember 2024 diskutieren Experten der Universität Heidelberg über innovative Behandlungsansätze für Glioblastome.
On December 20, 2024, experts from the Heidelberg University will discuss innovative treatment approaches for glioblastomas. (Symbolbild/DNAT)

New ways in the fight against malignant brain tumors: Glioblastom research

Heidelberg, Deutschland - On December 20, 2024, an revealing conversation about the treatment of malignant brain tumors took place, with journalist Wolfgang Heim with the leading neuroon pologens Dr. Sophie Heuer and Prof. Dr. Wolfgang Wick discussed. The focus of the discussion was the glioblastoma, one of the most aggressive forms of brain tumors. Prof. Wick, who works as a spokesman for the Collaborative Research Center (SFB) 1389, emphasized the need to develop new treatment strategies, since patients often suffer from therapy resistance as soon as conventional treatments are used, such as reported.

research approaches and new perspectives

The research of the SFB 1389, which received an extension in May 2024, focuses on the mechanisms of the intrinsic resistance of glioblastomas and the strategies that use tumor cells to escape the treatment methods. An innovative approach are the so -called "cancer neurosciences", which examine the communication between tumor cells and surrounding cells and are considered the key to overcoming treatment barriers. Prof. Wick and Dr. This year it pointed out that the understanding of these intercellular interactions is crucial for the success of therapy and enables significant progress in glioblastom research, such as

A central element of research is the "Core Collection", which integrates data from molecular analyzes, imaging methods and clinical results. These comprehensive data records are intended to help scientists to gain basic knowledge about the biology of the tumors and to develop new therapeutic approaches. Against the background of these important developments, the science community sees great hopes for more effective therapies for patients with glioblastomas.

Details
OrtHeidelberg, Deutschland
Quellen